Covered recipient · General Payments record
FARZAD R NAHAI
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$130,784.88
- Reported across 154 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,034.45 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $541.23 | 15 |
| REVANCE THERAPEUTICS, INC. | $353.95 | 6 |
| Kerecis Limited | $47.88 | 1 |
| Integra LifeSciences Corporation | $45.08 | 1 |
| MERZ NORTH AMERICA, INC. | $24.99 | 1 |
| Galderma Laboratories, L.P. | $21.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $124.90 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094185 | CMS |
| ABBVIE INC. | $29.26 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094187 | CMS |
| ABBVIE INC. | $117.86 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094189 | CMS |
| ABBVIE INC. | $24.57 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094191 | CMS |
| ABBVIE INC. | $11.23 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094193 | CMS |
| ABBVIE INC. | $0.62 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094195 | CMS |
| ABBVIE INC. | $0.41 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094197 | CMS |
| ABBVIE INC. | $3.18 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094199 | CMS |
| ABBVIE INC. | $89.19 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094201 | CMS |
| ABBVIE INC. | $4.79 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094203 | CMS |
| ABBVIE INC. | $95.27 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094205 | CMS |
| ABBVIE INC. | $2.87 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094207 | CMS |
| ABBVIE INC. | $12.42 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094209 | CMS |
| ABBVIE INC. | $21.53 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094211 | CMS |
| ABBVIE INC. | $3.13 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105094213 | CMS |
| Galderma Laboratories, L.P. | $21.32 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145318010 | CMS |
| Integra LifeSciences Corporation | $45.08 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140095225 | CMS |
| Kerecis Limited | $47.88 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120105940 | CMS |
| MERZ NORTH AMERICA, INC. | $24.99 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146369771 | CMS |
| REVANCE THERAPEUTICS, INC. | $154.02 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147925222 | CMS |
| REVANCE THERAPEUTICS, INC. | $74.46 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147925224 | CMS |
| REVANCE THERAPEUTICS, INC. | $42.34 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147925226 | CMS |
| REVANCE THERAPEUTICS, INC. | $15.09 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147925228 | CMS |
| REVANCE THERAPEUTICS, INC. | $9.80 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147925230 | CMS |
| REVANCE THERAPEUTICS, INC. | $58.24 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147925232 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.